| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.34 | 0.3 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.3 | 0.08 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.24 | 0.2 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | -0.21 | 0.06 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.19 | 9e-05 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.17 | 0.0009 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.17 | 0.0009 |